Clinical Research

   

Clinical Research for Amyloidosis in Africa

  Amyloidosis Africa is committed to advancing Africa-led clinical research to improve understanding of amyloidosis within African populations. Through structured, ethical, and collaborative research initiatives, we aim to generate locally relevant evidence that reflects the genetic diversity, clinical realities, and healthcare systems of African countries.   Although global recognition of amyloidosis has increased in recent years, African populations remain significantly underrepresented in the scientific literature. Data on disease prevalence, clinical presentation, diagnostic pathways, and patient outcomes across Africa are limited or entirely absent in many settings. This lack of local evidence continues to hinder timely diagnosis, appropriate care, and policy prioritization.   Africa-led research is essential to ensure that diagnostic strategies, clinical guidelines, and health system responses accurately reflect local patient needs and realities.  

Why Clinical Research Matters in Africa

  The absence of robust African data has serious consequences for both patients and healthcare systems. Without locally generated evidence, amyloidosis often remains invisible within national health strategies, clinical guidelines, and research agendas.   As a result:

• Clinicians may overlook amyloidosis in differential diagnoses
• Patients experience underdiagnosis and delayed presentation
• Health systems lack data to justify investment in diagnostics and care
• Policymakers underestimate the true burden of disease

  Moreover, African patients remain underrepresented in global amyloidosis research. This underrepresentation limits the applicability of international evidence to African populations and perpetuates inequities in knowledge generation and clinical decision-making.   By strengthening clinical research capacity in Africa, we help ensure that African populations are visible, represented, and appropriately considered in global amyloidosis science.  

Addressing Evidence Gaps Through Africa-Led Research

  Amyloidosis Africa focuses on closing critical evidence gaps by supporting research that originates from, and is led by, African clinicians and investigators. Rather than relying solely on externally driven studies, we prioritize research questions shaped by local clinical experience.   Key evidence gaps we address include:

• True prevalence of amyloidosis in African populations
• Patterns of clinical presentation and misdiagnosis
• Delays in diagnostic pathways
• Outcomes under real-world healthcare conditions
• Context-specific barriers to care

  Generating this evidence enables more accurate diagnosis, improved care pathways, and stronger advocacy for health system investment.  

What We Do

  Amyloidosis Africa supports and promotes clinical research initiatives focused on amyloidosis across the continent. Our research activities are designed to be scalable, ethical, and relevant to real-world clinical practice.   Observational and Real-World Studies We support observational studies that capture how amyloidosis presents and is managed in routine clinical settings. These studies provide valuable insights into diagnostic delays, referral patterns, and outcomes outside highly specialized centers.   Patient Registries and Data Platforms Registries form a cornerstone of sustainable research. By supporting patient registries and structured data platforms, we help create long-term resources that inform research, clinical care, and policy development. Registries also enable participation in future multicenter and international collaborations.   Collaborative Multicenter Research Projects Many African institutions lack sufficient case numbers to conduct meaningful single-center studies. Multicenter collaboration allows investigators to pool data, strengthen study design, and increase statistical power while maintaining local leadership and ownership.   Ethical and Equitable Research Practices All research initiatives supported by Amyloidosis Africa adhere to strong ethical standards.

• Ethical approval through local and national review bodies
• Informed consent and patient protection
• Data governance aligned with local regulations
• Respect for patient privacy and community trust

  In addition, we emphasize equitable partnerships. African investigators play central roles in study design, data ownership, analysis, and authorship. International collaborations are structured to support, not replace, local leadership.  

Capacity Building for African Investigators

 

• Early-career African researchers
• Clinicians transitioning into research roles
• Multidisciplinary research teams
• Skills development in study design, data analysis, and publication

  By investing in people as well as projects, we help build a sustainable pipeline of African researchers dedicated to amyloidosis and related conditions.  

Translating Research Into Impact

  Research must ultimately improve patient care. Therefore, Amyloidosis Africa works to ensure that research findings translate into real-world impact.   Research outputs contribute to:

• Improved diagnostic algorithms
• Better clinical awareness and education
• Evidence-based advocacy and policy engagement
• Quality improvement initiatives within health systems

 

Strengthening Africa’s Role in Global Amyloidosis Research

  By generating high-quality local evidence, African researchers contribute meaningfully to global amyloidosis knowledge. Strong African participation enriches global understanding of disease variability, genetics, and health system influences.   Through clinical research, Amyloidosis Africa helps position Africa not only as a site of study, but as a leader in shaping the global amyloidosis research agenda.  

Moving Research Forward Together

  Clinical research is essential to improving diagnosis, care, and outcomes for amyloidosis across Africa. By supporting Africa-led, ethically grounded, and collaborative research, Amyloidosis Africa works to close evidence gaps and strengthen health systems.   We welcome collaboration with clinicians, researchers, institutions, and partners committed to advancing amyloidosis research in Africa. Together, we can ensure that African data, expertise, and perspectives drive progress for patients across the continent.    

OUR DOCUMENTS